BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8136943)

  • 1. Interleukin-4 affects phenotype and proliferative response of peripheral blood lymphocytes from glioblastoma patients after specific or nonspecific in vitro stimulation.
    Faber C; Sandt G; Dang PT; Matgé G; Schiltz F; Heuschling P
    J Immunother Emphasis Tumor Immunol; 1994 Feb; 15(2):113-8. PubMed ID: 8136943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
    Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Deoxyspergualin inhibits interleukin 6 production in in vitro stimulated human lymphocytes.
    Borg AJ; Kumagai-Braesch M; Möller E
    Transpl Immunol; 1996 Jun; 4(2):133-43. PubMed ID: 8843590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4 enhances the in vitro precursor cell recruitment for tumor-specific T lymphocytes in patients with glioblastoma.
    Faber C; Terao E; Morga E; Heuschling P
    J Immunother; 2000 Jan; 23(1):11-6. PubMed ID: 10687133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes.
    Jacobs SK; Wilson DJ; Kornblith PL; Grimm EA
    J Neurosurg; 1986 Jan; 64(1):114-7. PubMed ID: 3001247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18.
    Kohyama M; Saijyo K; Hayasida M; Yasugi T; Kurimoto M; Ohno T
    Jpn J Cancer Res; 1998 Oct; 89(10):1041-6. PubMed ID: 9849583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
    Elliott LH; Brooks WH; Roszman TL
    J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of rheumatoid synovial fluid lymphocytes. II. A comparison of their behavior with blood mononuclear cells in the autologous mixed lymphocyte reaction and response to TCGF.
    Silver RM; Redelman D; Zvaifler NJ
    Clin Immunol Immunopathol; 1983 Apr; 27(1):15-27. PubMed ID: 6223751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro response of lymphocytes from bronchoalveolar lavage fluid and peripheral blood to mitogen stimulation during natural maedi-visna virus infection.
    Begara I; Luján L; Collie DS; Miller HR; Watt NJ
    Vet Immunol Immunopathol; 1995 Nov; 49(1-2):75-88. PubMed ID: 8588346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T lymphocytes.
    Talmadge JE; Wiltrout RH; Counts DF; Herberman RB; McDonald T; Ortaldo JR
    Cell Immunol; 1986 Oct; 102(2):261-72. PubMed ID: 3100057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 induces the expression of CD45RO and the memory phenotype by CD45RA+ peripheral blood lymphocytes.
    Roth MD
    J Exp Med; 1994 Mar; 179(3):857-64. PubMed ID: 8113679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte activation and cytokine production in autoimmune hemolytic anaemia (AIHA).
    Fagiolo E; Abenante L
    Autoimmunity; 1996; 24(3):147-56. PubMed ID: 9020407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Ohno T
    J Hematother; 1999 Feb; 8(1):29-37. PubMed ID: 10192299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation.
    Klingemann HG; Kohn FR; Phillips GL
    Eur Cytokine Netw; 1991; 2(2):131-6. PubMed ID: 1813016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
    Wang H; Daniel V; Sadeghi M; Opelz G
    Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Emperipolesis of pre-stimulated lymphocytes].
    Yang JZ; Ma L; He XW; Zhou MQ; Hu ZM; Wang XN
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1124-7. PubMed ID: 16174578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor.
    Elliott LH; Brooks WH; Roszman TL
    J Neurooncol; 1992 Sep; 14(1):1-7. PubMed ID: 1335042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
    Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
    Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.